Skip to content

Whether homoeopathic medicines can help people handle stress and adjust better during difficult life changes

Role Of Individualized Homoeopathic Medicine In Case Of Adjustment Disorder At The Age Group Of 18-35 Year Assessed By Dass-21 Scale A Prospective Experimental Study - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097539
Enrollment
40
Registered
2025-11-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F432- Adjustment disorders

Interventions

Intervention1: individualized homeopathic medicine: potency various such as a Decimal Centasimal 50Milesimal etc doses as per need of cases Medicines will be dispensed as per the potency Frequency as

Sponsors

Dr Palak Pandya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Age group of 18-35 year 2)Both gender 3)Patient should be selected on the basis of ICD 11 code of 6B43 4)Must provide written informed consent. 5)DASS-21 Score level within the if depression level is 21-27, anxiety level 15-19, stress level 26-33.

Exclusion criteria

Exclusion criteria: 1)Severe Mental Health Disorders: Diagnosed with Major Depressive Disorder (MDD), Generalized Anxiety Disorder (GAD), Panic Disorder, Post-Traumatic Stress Disorder (PTSD), or Psychotic Disorderes. 2)Any history of bipolar disorder or schizophrenia. 3)Individuals with active suicidal thoughts or self-harm behaviours. Current or past alcohol or drug dependence affecting emotional stability. 4)Severe neurological disorders, autoimmune diseases, or endocrine disorders that could interfere with the study outcomes. 5)Participants receiving CBT, counseling, antidepressants, anxiolytics, or any psychiatric medication during the study. 6)Individuals who have undergone homeopathic treatment for Adjustment Disorder in the past 3 months. 7)Those unwilling or unable to attend follow-ups at 4, 8, and 12 weeks. 8)Women who are pregnant or breastfeeding due to potential hormonal influences on mood.

Design outcomes

Primary

MeasureTime frame
DASS-21 ScaleTimepoint: Data will be assessed from baseline 4,8,12 weeks but i will consider only baseline and end of treatment

Secondary

MeasureTime frame
NOT APPLICABLETimepoint: NOT APPLICABLE

Countries

India

Contacts

Public ContactDr Palak Pandya

Smt A J Savla Homeopathic medical college and research institute

dr.rvsutariya02@gmail.com8140415881

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026